Clinical Trial: An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527832) titled 'An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.' on April 07.

Brief Summary: The purpose of this study is to look at the safety of BEVACIZUMAB BS [Pfizer] when it was used to colorectal cancer patients in real-world clinical setting in Japan.

The study population includes individuals who have a diagnosis of colorectal cancer and have been treated with Bevacizumab-Pfizer Biosimilar or Avastin between 1 December 2019 and 30 November 2024.

Data source is the Medical Data Vision (MDV) database - a hospital-based claims database in Japan.

Study Start Date: May 01...